3T Biosciences Alternatives & Competitors
12 companies similar to 3T Biosciences — 3T is an immunotherapy company developing next-generation, transformative therap...
Companies similar to 3T Biosciences
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Glycyx
Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...
TScan Therapeutics
Unleash Immunity
Track all 3T Biosciences competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Umoja Biopharma
Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Gracell Biotechnologies
A Member of the AstraZeneca Group
Revitope
Powered for Precision: Revolutionizing immunotherapy to safely and effectively treat more...
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therap...
About 3T Biosciences
3T Biosciences, founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma and Biotechnology sectors. The company is dedicated to revolutionizing immunotherapy by developing next-generation therapies aimed at treating solid tumors and other immune-mediated diseases. Their unique appr...
Development of transformative therapies, Treatment for solid tumors, Innovative immunotherapy solutions
Patients with solid tumors, Broad patient populations, Healthcare providers
Immunotherapy, Next-generation Therapies, Transformative Therapies, Solid Tumors, Immune-mediated Diseases, Broad Patient Populations, Cancer Treatment, Immune System Leveraging, Cell-targeting Technology, Safer Cancer Therapies, Effective Cancer Treatments, Curative Therapies, Difficult-to-treat Cancers, Oncology
B2B, B2C, B2D
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches 3T Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at 3T Biosciences on 4 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.